Quanterix launches PhenoCode 2.0 molecular barcoding kit for spatial biology assays

By Public Technologies
  • Quanterix reported progress at ESSB 2026 on its spatial biology content roadmap tied to Akoya integration and SIMOA-based assay development.
  • PhenoCode 2.0 Molecular Barcoding Kit moved from early access to full commercial release, enabling researchers to barcode antibodies for high-plex assays.
  • Two PhenoCycler-Fusion spike-in modules compatible with the IO60 panel were confirmed for shipment in Q4 2026.
  • Those modules include a TIME panel for broader tumor immune microenvironment profiling and a high-plex ADC panel combining ADC targets with immune context.
  • Accelerator Laboratory Services began taking requests for custom ADC panel development, spanning discovery through clinical trial testing under CLIA, GCLP, ISO 15189.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quanterix Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202609250800BIZWIRE_USPR_____20260925_BW369199) on September 25, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk